Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
PHASE2
Diarrhoea is the most commonly reported adverse event (AE) associated with ...
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
N/A
The goal of this clinical trial is to evaluate the diagnostic efficacy of s...
Status
Recruiting
Location
Nanjing First Hospital
Start Date
2024-12-25
Trial ID
NCT07195500
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
PHASE2
Acromegaly is a rare, serious condition characterized by chronic hypersecre...
Status
Completed
Location
Cedars Sinai Medical Center Dept. of Pituitary Ctr.